Lusutrombopag News
Lusutrombopag currently has 0 news articles, with 10 predicted indications.
This page combines the AI-predicted indications for Lusutrombopag with the latest health news. Indications highlighted in orange have recent news coverage.
Drug Information
- Original indication: Mulpleo is indicated for the treatment of severe thrombocytopenia in adult patients with chronic liver disease undergoing invasive procedures
- Evidence level: L5
- Predicted indications (10):
- hereditary thrombocytopenia with normal platelets (100.0%)
- marcothrombocytopenia with mitral valve insufficiency (100.0%)
- transient neonatal thrombocytopenia (100.0%)
- dense granule disease (100.0%)
- platelet storage pool deficiency (100.0%)
- amyotrophic lateral sclerosis (100.0%)
- lower motor neuron syndrome with late-adult onset (100.0%)
- amyotrophic lateral sclerosis, susceptibility to (100.0%)
- bilateral parasagittal parieto-occipital polymicrogyria (100.0%)
- axial spondylometaphyseal dysplasia (99.9%)
Related News (0)
No related news yet. When news mentions this drug, it will be collected and shown here automatically.
Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.